The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy

Christopher Fraker; Allison L Bayer

doi:10.1007/s11892-016-0806-7

The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy

Christopher Fraker, Allison L Bayer

Research output: Contribution to journal › Review article

11 Scopus citations

Abstract

Treatments for autoimmune diseases including type 1 diabetes (T1D) are aimed at resetting the immune system, especially its adaptive arm. The innate immune system is often ignored in the design of novel immune-based therapies. There is increasing evidence for multiple natural killer (NK) subpopulations, but their role is poorly understood in autoimmunity and likely is contributing to the controversial role reported for NKs. In this review, we will summarize NK subsets and their roles in tolerance, autoimmune diabetes, and immunotherapy.

Original language	English (US)
Article number	109
Journal	Current Diabetes Reports
Volume	16
Issue number	11
DOIs	https://doi.org/10.1007/s11892-016-0806-7
State	Published - Nov 1 2016

Keywords

Diabetes
Natural killer cells
Tolerance

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s11892-016-0806-7

Fingerprint Dive into the research topics of 'The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy'. Together they form a unique fingerprint.

Cite this

Fraker, C., & Bayer, A. L. (2016). The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy. Current Diabetes Reports, 16(11), [109]. https://doi.org/10.1007/s11892-016-0806-7

@article{e3a148c1e34b42e08ef06752079465c9,

title = "The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy",

abstract = "Treatments for autoimmune diseases including type 1 diabetes (T1D) are aimed at resetting the immune system, especially its adaptive arm. The innate immune system is often ignored in the design of novel immune-based therapies. There is increasing evidence for multiple natural killer (NK) subpopulations, but their role is poorly understood in autoimmunity and likely is contributing to the controversial role reported for NKs. In this review, we will summarize NK subsets and their roles in tolerance, autoimmune diabetes, and immunotherapy.",

keywords = "Diabetes, Natural killer cells, Tolerance",

author = "Christopher Fraker and Bayer, {Allison L}",

year = "2016",

month = nov,

day = "1",

doi = "10.1007/s11892-016-0806-7",

language = "English (US)",

volume = "16",

journal = "Current Diabetes Reports",

issn = "1534-4827",

publisher = "Current Medicine Group",

number = "11",

}

TY - JOUR

T1 - The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy

AU - Fraker, Christopher

AU - Bayer, Allison L

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Treatments for autoimmune diseases including type 1 diabetes (T1D) are aimed at resetting the immune system, especially its adaptive arm. The innate immune system is often ignored in the design of novel immune-based therapies. There is increasing evidence for multiple natural killer (NK) subpopulations, but their role is poorly understood in autoimmunity and likely is contributing to the controversial role reported for NKs. In this review, we will summarize NK subsets and their roles in tolerance, autoimmune diabetes, and immunotherapy.

AB - Treatments for autoimmune diseases including type 1 diabetes (T1D) are aimed at resetting the immune system, especially its adaptive arm. The innate immune system is often ignored in the design of novel immune-based therapies. There is increasing evidence for multiple natural killer (NK) subpopulations, but their role is poorly understood in autoimmunity and likely is contributing to the controversial role reported for NKs. In this review, we will summarize NK subsets and their roles in tolerance, autoimmune diabetes, and immunotherapy.

KW - Diabetes

KW - Natural killer cells

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=84988662467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988662467&partnerID=8YFLogxK

U2 - 10.1007/s11892-016-0806-7

DO - 10.1007/s11892-016-0806-7

M3 - Review article

C2 - 27664042

AN - SCOPUS:84988662467

VL - 16

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 11

M1 - 109

ER -